Jacob Rae
Kirkland & Ellis LLP
- Address of record
- 601 Lexington Avenue, New York, NY 10022, 212-446-4800
- Phone
- (212) 446-4800
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
Oral Phenylephrine Marketing Class Action
A proposed class action concerning marketing and sales practices for oral phenylephrine products, apparently alleging that defendants made false or misleading claims about the products. The case was recently filed and these are allegations, not proven facts.
- Filed
- December 6, 2023
- Represents
- GlaxoSmithKline LLC, Haleon Us Capital LLC, Haleon PLC, Pfizer Inc., GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
EQT Corporation Securities Litigation Settlement
EQT Corporation shareholders allege they suffered losses in connection with the acquisition of Rice Midstream Partners. The defendants are accused of making misstatements regarding the transaction. The company has agreed to settle the securities litigation for $167.5 million without admitting wrongdoing.
- Settlement fund
- $167.5M
- Claim deadline
- December 10, 2025
- Represents
- DANIEL J. RICE, IV, ROBERT F. VAGT, DAVID E. SCHLOSSER, JR., EQT CORPORATION, STEVEN T. SCHLOTTERBECK, ROBERT J. MCNALLY, DAVID L. PORGES, JIMMI SUE SMITH, JAMES E. ROHR, VICKY A. BAILEY, PHILIP G. BEHRMAN, KENNETH M. BURKE, A. BRAY CARY, JR., MARGARET K. DORMAN, LEE T. TODD, JR., CHRISTINE J. TORETTI
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.